Trellus Health plc logo

Trellus Health plc (TRLS)

Market Closed
11 Aug, 15:30
LSE LSE
0. 00
GBX
0
0%
GBX
1.65M Market Cap
- P/E Ratio
- Div Yield
69.99M Volume
- Eps
0 GBX
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 2.34
Want to track TRLS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

TRLS closed yesterday higher at 0 GBX, an increase of 0% from Monday's close, completing a monthly increase of 0% or 0 GBX. Over the past 12 months, TRLS stock lost -99.68%.
TRLS is not paying dividends to its shareholders.
The last earnings report, released on Jun 01, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

TRLS Chart

People also search for

FEN
Frenkel Topping Group Plc
0.5 GBX
-99%
VLE
Volvere plc
2,110 GBX
0%
CAV
Cavendish Financial plc
9.88 GBX
+1.2821%
Onward Opportunities Ltd.
133 GBX
+4.7244%
JIM
Jarvis Securities plc
7.75 GBX
-3.125%

Trellus Health plc (TRLS) FAQ

What is the stock price today?

The current price is 0.00 GBX.

On which exchange is it traded?

Trellus Health plc is listed on LSE.

What is its stock symbol?

The ticker symbol is TRLS.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.65M.

Has Trellus Health plc ever had a stock split?

No, there has never been a stock split.

Trellus Health plc Profile

Insurance Industry
Financials Sector
Dr. Marla Cindy Dubinsky M.D. CEO
LSE Exchange
GB00BNNFM402 ISIN
United States Country
31 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Trellus Health plc is a pioneering company dedicated to transforming the management of chronic conditions, with a specific focus on inflammatory bowel diseases such as Crohn's Disease and ulcerative colitis. Founded in 2020 and based in White Plains, New York, Trellus Health employs digital technology to enhance the way employers and health plans support individuals battling chronic diseases. The company is distinguished by its innovative approach to care, leveraging a proprietary technology platform named TrellusElevate, designed under strict HIPAA compliance to ensure privacy and security in telemedicine applications. Trellus Health's mission is to streamline the care process, making expert guidance and support readily accessible to patients, hence improving their quality of life and health outcomes.

Products and Services

  • TrellusElevate Platform
  • A cornerstone of Trellus Health’s offerings, the TrellusElevate platform represents the fusion of technology and personalized healthcare. This HIPAA-compliant technology solution is engineered to remotely coordinate and deliver comprehensive care for individuals with chronic conditions, specifically targeting inflammatory bowel diseases. Through TrellusElevate, patients gain access to a tailored care team, ensuring a cohesive approach to managing their health. The platform facilitates telemedicine consultations, enabling patients to receive expert medical advice without the need for in-person visits. Furthermore, TrellusElevate enriches the patient experience with an array of educational content, aimed at empowering individuals with knowledge about their conditions and how best to manage them. Remote monitoring features are also integrated, allowing the care team to closely follow the patient’s health status and adjust treatment plans accordingly.

Contact Information

Address: 44 South Broadway
Phone: 800 866 4165